,Set,NGenes,Direction,PValue,FDR
1,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Down,0.000200708262037855,0.164982191395117
2,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,25,Down,0.000630967777582325,0.259327756586336
3,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Down,0.00111776995703798,0.260444593206262
4,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,33,Down,0.0014476283687591,0.260444593206262
5,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,32,Down,0.00184839164739383,0.260444593206262
6,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.00190105542486323,0.260444593206262
7,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,0.00274875096000386,0.322781898446168
8,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,0.00395191293716345,0.36551673009497
9,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.00462875080820794,0.36551673009497
10,WP_ZINC_HOMEOSTASIS,21,Up,0.00491012229055087,0.36551673009497
11,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.00517580724940113,0.36551673009497
12,WP_REGULATION_OF_ACTIN_CYTOSKELETON,88,Down,0.00533601065832073,0.36551673009497
13,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.00613610214955021,0.367590008729737
14,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.00676317096417704,0.367590008729737
15,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.00730214909108348,0.367590008729737
16,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,17,Down,0.0076018971092427,0.367590008729737
17,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Down,0.00892452268372425,0.367590008729737
18,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Up,0.00902094597792479,0.367590008729737
19,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.00945437421446469,0.367590008729737
20,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,86,Down,0.0106372993714932,0.367590008729737
21,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.0106918968676131,0.367590008729737
22,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.0107969930491038,0.367590008729737
23,WP_BENZENE_METABOLISM,3,Up,0.0112964058048134,0.367590008729737
24,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.0117545493615119,0.367590008729737
25,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.0124368962272439,0.367590008729737
26,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Down,0.0132509774117291,0.367590008729737
27,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.0136102116629505,0.367590008729737
28,WP_ERBB_SIGNALING,67,Down,0.0137318487000911,0.367590008729737
29,WP_TOLLLIKE_RECEPTOR_SIGNALING,77,Down,0.0140790138163802,0.367590008729737
30,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.0141241886715926,0.367590008729737
31,WP_CREATINE_PATHWAY,2,Down,0.0142780680977822,0.367590008729737
32,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.0145949216808411,0.367590008729737
33,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,11,Up,0.0150450425324525,0.367590008729737
34,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Down,0.0154304744090789,0.367590008729737
35,WP_IL26_SIGNALING,31,Down,0.0156516427074706,0.367590008729737
36,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.0174693652915068,0.39888384082274
37,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.0185088568035791,0.411196764663299
38,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,0.020717089793644,0.43988282985744
39,WP_BLOOD_CLOTTING_CASCADE,5,Up,0.0211655189227995,0.43988282985744
40,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,76,Down,0.0214054905040117,0.43988282985744
41,WP_ALLOGRAFT_REJECTION,48,Down,0.0235195958140508,0.471539213637799
42,WP_RANKLRANK_SIGNALING,47,Down,0.0263533608661672,0.49081526788603
43,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.0274818281248044,0.49081526788603
44,WP_ACE_INHIBITOR_PATHWAY,4,Down,0.0280921864713972,0.49081526788603
45,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.0287624375439683,0.49081526788603
46,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,48,Up,0.0290643786333714,0.49081526788603
47,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,59,Down,0.029130201464312,0.49081526788603
48,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Down,0.0291517245552065,0.49081526788603
49,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Down,0.0295222392368601,0.49081526788603
50,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.02985494330207,0.49081526788603
51,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.031094047830519,0.500556794904977
52,WP_CHOLESTEROL_METABOLISM,52,Down,0.0320402973811284,0.500556794904977
53,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.0322743432238002,0.500556794904977
54,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.0355993939564757,0.526058391508056
55,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Down,0.036102319233265,0.526058391508056
56,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.036196782708439,0.526058391508056
57,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.0364785016009236,0.526058391508056
58,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Down,0.03725836400896,0.528040951989054
59,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.0397209165567218,0.55017127282233
60,WP_NEUROINFLAMMATION,10,Down,0.0401584870673234,0.55017127282233
61,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.0419959359048426,0.557801927353037
62,WP_LEPTIN_SIGNALING,69,Down,0.042072651454852,0.557801927353037
63,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.045428275275731,0.57783764506839
64,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.0457142368370694,0.57783764506839
65,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Up,0.0460254913753956,0.57783764506839
66,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.0471788808151609,0.57783764506839
67,WP_NETRINUNC5B_SIGNALING,35,Down,0.0478879449163186,0.57783764506839
68,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.048248301472153,0.57783764506839
69,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.0485046198415072,0.57783764506839
70,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.0511280648813391,0.594160997919681
71,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,26,Down,0.0513204754894129,0.594160997919681
72,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.0523352422108534,0.59560415363784
73,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.0537296395945809,0.59560415363784
74,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.0550524857759137,0.59560415363784
75,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,80,Down,0.0552271734417844,0.59560415363784
76,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.0556812401698345,0.59560415363784
77,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Down,0.0565100199737764,0.59560415363784
78,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.0566015829633207,0.59560415363784
79,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.0580100363412928,0.59560415363784
80,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Down,0.060475473236407,0.59560415363784
81,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,6,Down,0.0604763160858477,0.59560415363784
82,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.0605573595891854,0.59560415363784
83,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.0606850462485937,0.59560415363784
84,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Up,0.063044021939494,0.59560415363784
85,WP_ENDOCHONDRAL_OSSIFICATION,25,Up,0.0630644733474453,0.59560415363784
86,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,25,Up,0.0630644733474453,0.59560415363784
87,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Up,0.0634487622311544,0.59560415363784
88,WP_TYPE_II_DIABETES_MELLITUS,13,Down,0.0653158990142631,0.59560415363784
89,WP_ATR_SIGNALING,10,Up,0.0662957705513155,0.59560415363784
90,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.0672461255840635,0.59560415363784
91,WP_CHEMOKINE_SIGNALING,107,Down,0.0674648599268274,0.59560415363784
92,WP_DNA_DAMAGE_RESPONSE,57,Up,0.068133378144005,0.59560415363784
93,WP_MAPK_CASCADE,30,Down,0.0689862832924138,0.59560415363784
94,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.0692924454572693,0.59560415363784
95,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.0693242194148428,0.59560415363784
96,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Down,0.0701945164320099,0.59560415363784
97,WP_DOPAMINE_METABOLISM,7,Up,0.0702841884463145,0.59560415363784
98,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.0728722955625882,0.604652803516418
99,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.0732804163645429,0.604652803516418
100,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,68,Up,0.0735587352209754,0.604652803516418
101,WP_PURINE_METABOLISM,9,Down,0.0746890006380203,0.60786493588567
102,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.0755719400060643,0.609020928284165
103,WP_AEROBIC_GLYCOLYSIS,10,Up,0.0774019781086178,0.611290891085168
104,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.0774019781086178,0.611290891085168
105,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,44,Up,0.0780846028758427,0.611290891085168
106,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,31,Down,0.081140246614152,0.619596480029144
107,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,24,Down,0.0812642802062846,0.619596480029144
108,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.0814068367921504,0.619596480029144
109,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.0825082507657937,0.62221818467415
110,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.083491878069733,0.623912034302914
111,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.0856264075180808,0.634098261079842
112,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.0878770665679754,0.640022739890094
113,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.0879836613230908,0.640022739890094
114,WP_IRINOTECAN_PATHWAY,5,Up,0.0905818403939347,0.65176493666542
115,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.091231508008632,0.65176493666542
116,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.0924041524015983,0.65176493666542
117,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,20,Down,0.0944462975179064,0.65176493666542
118,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.096646077106421,0.65176493666542
119,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,70,Up,0.0968982425627479,0.65176493666542
120,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,8,Down,0.0989372230618686,0.65176493666542
121,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,8,Down,0.0989372230618686,0.65176493666542
122,WP_ESTROGEN_SIGNALING,21,Down,0.0998707449821412,0.65176493666542
123,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,83,Down,0.0999478890686769,0.65176493666542
124,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.101858011689822,0.65176493666542
125,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.102087385456165,0.65176493666542
126,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.103109984689829,0.65176493666542
127,WP_OSTEOBLAST_SIGNALING,2,Down,0.103422272728931,0.65176493666542
128,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.10350064331013,0.65176493666542
129,WP_SEROTONIN_TRANSPORTER_ACTIVITY,3,Down,0.103643329079798,0.65176493666542
130,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Up,0.10372243975435,0.65176493666542
131,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.103870081147409,0.65176493666542
132,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.104729275932546,0.652177763761767
133,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.105699940014497,0.653273313473055
134,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,69,Down,0.109043990034299,0.659443305712198
135,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.109492316895827,0.659443305712198
136,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,29,Up,0.110452595429276,0.659443305712198
137,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Down,0.110654531829301,0.659443305712198
138,WP_SILDENAFIL_TREATMENT,10,Down,0.11070946008307,0.659443305712198
139,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,34,Down,0.113509963856587,0.669018381532217
140,WP_MONOAMINE_GPCRS,3,Up,0.113944736514003,0.669018381532217
141,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.115438997391733,0.672984793304997
142,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.116486300530565,0.674308021381161
143,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.118578828951732,0.679694688577189
144,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,36,Down,0.119395740116881,0.679694688577189
145,WP_GASTRIC_CANCER_NETWORK_2,24,Down,0.122103025284759,0.679694688577189
146,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Down,0.122754549485284,0.679694688577189
147,WP_ENDOMETRIAL_CANCER,48,Down,0.123709160361715,0.679694688577189
148,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,20,Up,0.12454464721783,0.679694688577189
149,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.125097072903572,0.679694688577189
150,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.125217042539883,0.679694688577189
151,WP_INTEGRINMEDIATED_CELL_ADHESION,71,Down,0.125602492238159,0.679694688577189
152,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.125685635843957,0.679694688577189
153,WP_TRYPTOPHAN_METABOLISM,18,Up,0.127935165587647,0.68043791322665
154,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.129439361606967,0.68043791322665
155,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.129842965456498,0.68043791322665
156,WP_PHOSPHOINOSITIDES_METABOLISM,37,Down,0.130628406460421,0.68043791322665
157,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.13206548147138,0.68043791322665
158,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.13206548147138,0.68043791322665
159,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.132105138500646,0.68043791322665
160,WP_OREXIN_RECEPTOR_PATHWAY,116,Down,0.132880119221087,0.68043791322665
161,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,46,Up,0.133400329668885,0.68043791322665
162,WP_MTHFR_DEFICIENCY,18,Up,0.134100902606712,0.68043791322665
163,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,27,Down,0.135286497345016,0.682242336304313
164,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.136318084742328,0.68325283937923
165,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Up,0.137875268371545,0.686869518796423
166,WP_IL5_SIGNALING,37,Down,0.138742233408844,0.687024794349819
167,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.142156318936189,0.699715533925434
168,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.143202487004383,0.700669311414303
169,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.144964949399376,0.705095789386313
170,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,24,Up,0.147331526198169,0.712391261969969
171,WP_ONCOSTATIN_M_SIGNALING,55,Down,0.148794428044572,0.713123966385498
172,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.14921815355025,0.713123966385498
173,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.150774104779032,0.716394879354709
174,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.154123278833102,0.723411763581862
175,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,58,Up,0.154466883696169,0.723411763581862
176,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,10,Up,0.155458930081381,0.723411763581862
177,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.157815133876089,0.723411763581862
178,WP_GPR40_PATHWAY,7,Down,0.158045098068843,0.723411763581862
179,WP_NPHP1_DELETION_SYNDROME,10,Down,0.158873674056489,0.723411763581862
180,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,104,Down,0.159439634771727,0.723411763581862
181,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.160945187536527,0.723411763581862
182,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,45,Down,0.16172953961194,0.723411763581862
183,WP_IL17_SIGNALING,25,Down,0.162703249100009,0.723411763581862
184,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.164198709543022,0.723411763581862
185,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,6,Down,0.164367261226733,0.723411763581862
186,WP_CELL_CYCLE,89,Up,0.165814140376829,0.723411763581862
187,WP_METABOLIC_EPILEPTIC_DISORDERS,57,Up,0.167765958518689,0.723411763581862
188,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.168827089078532,0.723411763581862
189,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.170977340376894,0.723411763581862
190,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.171152389098105,0.723411763581862
191,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.173205503081244,0.723411763581862
192,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,71,Up,0.175239523771352,0.723411763581862
193,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.175482747209629,0.723411763581862
194,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.175940135525298,0.723411763581862
195,WP_PPAR_SIGNALING,39,Down,0.176026266525149,0.723411763581862
196,WP_GLYOXYLATE_METABOLISM,5,Up,0.176041807191612,0.723411763581862
197,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,55,Down,0.177182775481403,0.723411763581862
198,WP_VITAMIN_B12_METABOLISM,23,Down,0.177582458990111,0.723411763581862
199,WP_BENZOAPYRENE_METABOLISM,5,Up,0.177675839503603,0.723411763581862
200,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.17907706475583,0.723411763581862
201,WP_INSULIN_SIGNALING,129,Down,0.180347003700706,0.723411763581862
202,WP_SMALL_CELL_LUNG_CANCER,66,Down,0.180578884363331,0.723411763581862
203,WP_MONOAMINE_TRANSPORT,11,Down,0.180956908594442,0.723411763581862
204,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,6,Down,0.181633232281294,0.723411763581862
205,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,15,Up,0.182505072587303,0.723411763581862
206,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.18306211932803,0.723411763581862
207,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Up,0.183877396831257,0.723411763581862
208,WP_NRF2ARE_REGULATION,20,Up,0.185228199692118,0.723411763581862
209,WP_IRON_METABOLISM_IN_PLACENTA,8,Down,0.186081001653023,0.723411763581862
210,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.186265685508821,0.723411763581862
211,WP_VITAMIN_D_RECEPTOR_PATHWAY,80,Down,0.187020165461723,0.723411763581862
212,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.18743360673237,0.723411763581862
213,WP_MACROPHAGE_MARKERS,8,Down,0.187453413190921,0.723411763581862
214,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,162,Down,0.189986681084416,0.729761924539205
215,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Up,0.193138994384049,0.731679857723265
216,WP_GLUCURONIDATION,7,Up,0.194372804090416,0.731679857723265
217,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.194709577004114,0.731679857723265
218,WP_JOUBERT_SYNDROME,70,Up,0.196033423521681,0.731679857723265
219,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.196735728325581,0.731679857723265
220,WP_MELANOMA,52,Down,0.196818161356893,0.731679857723265
221,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.197750928864524,0.731679857723265
222,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.198132899850052,0.731679857723265
223,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.199100076578615,0.731679857723265
224,WP_GASTRIN_SIGNALING,92,Down,0.20209135370306,0.731679857723265
225,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Up,0.203917183166862,0.731679857723265
226,WP_KIT_RECEPTOR_SIGNALING,50,Down,0.204599261947979,0.731679857723265
227,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.205444874162,0.731679857723265
228,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,53,Up,0.206174828944343,0.731679857723265
229,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,32,Down,0.209166617580463,0.731679857723265
230,WP_LUNG_PATHOLOGY_OF_COVID19,13,Down,0.210272589184909,0.731679857723265
231,WP_OSTEOPONTIN_SIGNALING,10,Down,0.211209460883927,0.731679857723265
232,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.211229682061217,0.731679857723265
233,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,17,Down,0.213360957435427,0.731679857723265
234,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Up,0.213541999309094,0.731679857723265
235,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.213705133254863,0.731679857723265
236,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.213929861035912,0.731679857723265
237,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.213929861035912,0.731679857723265
238,WP_IL1_SIGNALING,51,Down,0.214162514463128,0.731679857723265
239,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,11,Down,0.214658094679416,0.731679857723265
240,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,47,Down,0.215047984691924,0.731679857723265
241,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.215842078824631,0.731679857723265
242,WP_FOLATE_METABOLISM,36,Down,0.216353972797826,0.731679857723265
243,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Up,0.217294973654152,0.731679857723265
244,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,59,Up,0.21835960326033,0.731679857723265
245,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.219509651913294,0.731679857723265
246,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.21993624998801,0.731679857723265
247,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,38,Up,0.220098863889091,0.731679857723265
248,WP_NGLYCAN_BIOSYNTHESIS,51,Up,0.221409221272233,0.731679857723265
249,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.221640248872376,0.731679857723265
250,WP_NRF2_PATHWAY,67,Up,0.223305780781836,0.732391156438842
251,WP_KININKALLIKREIN_PATHWAY,2,Up,0.223886283965847,0.732391156438842
252,WP_THERMOGENESIS,72,Down,0.224528675696579,0.732391156438842
253,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,169,Down,0.226520317260873,0.735967196792245
254,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.228307090219479,0.7388520793717
255,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,19,Down,0.229431051160568,0.739577741388185
256,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.231842714931156,0.744432467474259
257,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.235096108740425,0.751941639628907
258,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.237299681809146,0.753474083906044
259,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Down,0.237408500890104,0.753474083906044
260,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.23851729545632,0.754081603327287
261,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.241474747016061,0.760506674510353
262,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.243074130478111,0.762621890278654
263,WP_ACUTE_MYELOID_LEUKEMIA,54,Down,0.244526693972273,0.764262138574937
264,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,16,Down,0.245920412822486,0.76570673992456
265,WP_B_CELL_RECEPTOR_SIGNALING,83,Down,0.249035251581292,0.772479157735179
266,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.250229893906038,0.773266815002869
267,WP_IL18_SIGNALING,185,Down,0.253898868158611,0.779193564727158
268,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,0.254310043674053,0.779193564727158
269,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.257063129785468,0.779193564727158
270,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.257409468782028,0.779193564727158
271,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Up,0.257833531653384,0.779193564727158
272,WP_TRANSLATION_FACTORS,49,Down,0.257835340153025,0.779193564727158
273,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.259404403117254,0.781063807188217
274,WP_SERINE_METABOLISM,5,Down,0.264531981293248,0.791360324492138
275,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,10,Up,0.265020871757657,0.791360324492138
276,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.265712225741886,0.791360324492138
277,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.270740298309004,0.803424278736466
278,WP_G1_TO_S_CELL_CYCLE_CONTROL,48,Up,0.272143544903338,0.804683431332892
279,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Up,0.275302357130665,0.807028632820221
280,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.27574122719925,0.807028632820221
281,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.275886003933463,0.807028632820221
282,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.277039588025388,0.807028632820221
283,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.277845624194796,0.807028632820221
284,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.283097322298168,0.817198926677855
285,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Down,0.283335394286118,0.817198926677855
286,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.285146931912645,0.819548174937741
287,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.287932716496387,0.823686411788162
288,WP_HYPERTROPHY_MODEL,12,Down,0.289175865015357,0.823686411788162
289,WP_15Q11Q13_COPY_NUMBER_VARIATION,31,Up,0.290043674474462,0.823686411788162
290,WP_TAR_SYNDROME,43,Down,0.292851870233044,0.823686411788162
291,WP_MEVALONATE_PATHWAY,7,Down,0.29302106183512,0.823686411788162
292,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.293431008223931,0.823686411788162
293,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.293601117583858,0.823686411788162
294,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.296238988019722,0.82826002772861
295,WP_HOMOLOGOUS_RECOMBINATION,11,Up,0.298456660857041,0.831631780421994
296,WP_PROLACTIN_SIGNALING,68,Down,0.301184379426078,0.836397161784581
297,WP_CAMKK2_PATHWAY,29,Up,0.302822732855606,0.83811544244885
298,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.304400796172814,0.838171286130191
299,WP_MALE_INFERTILITY,65,Down,0.306086347834073,0.838171286130191
300,WP_APOPTOSIS_MODULATION_AND_SIGNALING,75,Down,0.306092559648696,0.838171286130191
301,WP_TGFBETA_RECEPTOR_SIGNALING,33,Down,0.307806101014068,0.838171286130191
302,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.311719330425622,0.838171286130191
303,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Down,0.311891038377129,0.838171286130191
304,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.313463747324415,0.838171286130191
305,WP_SMALL_LIGAND_GPCRS,7,Up,0.316080977206753,0.838171286130191
306,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Up,0.316254162707502,0.838171286130191
307,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.317366292888532,0.838171286130191
308,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.318461866160901,0.838171286130191
309,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Up,0.318591353418572,0.838171286130191
310,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,38,Up,0.318782896828867,0.838171286130191
311,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.321184859750778,0.838171286130191
312,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.322247452573271,0.838171286130191
313,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.322563838358847,0.838171286130191
314,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,14,Down,0.323980711424086,0.838171286130191
315,WP_GLIOBLASTOMA_SIGNALING,65,Down,0.32452506319137,0.838171286130191
316,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.324674612419389,0.838171286130191
317,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,58,Down,0.325249221091196,0.838171286130191
318,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.325727169077599,0.838171286130191
319,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.327121026033533,0.838171286130191
320,WP_TCELL_RECEPTOR_SIGNALING,71,Down,0.327148156653923,0.838171286130191
321,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Up,0.327315064291717,0.838171286130191
322,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,36,Down,0.328763683443261,0.839266297485592
323,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.331586661368348,0.843621154111848
324,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.334428309063207,0.843621154111848
325,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Down,0.335516442928032,0.843621154111848
326,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Down,0.336759728290061,0.843621154111848
327,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.337616336491436,0.843621154111848
328,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,10,Up,0.338016198488921,0.843621154111848
329,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,54,Down,0.340300353987915,0.843621154111848
330,WP_ALPHA_6_BETA_4_SIGNALING,25,Down,0.341554548828625,0.843621154111848
331,WP_LUNG_FIBROSIS,29,Down,0.341775307919627,0.843621154111848
332,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.342330407356561,0.843621154111848
333,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.343021647868081,0.843621154111848
334,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Up,0.34356528400789,0.843621154111848
335,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Down,0.344074795483234,0.843621154111848
336,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.345049826242672,0.843621154111848
337,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,63,Down,0.345864147123714,0.843621154111848
338,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Down,0.347097403083316,0.844124453652326
339,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,16,Down,0.348929727559491,0.846077392489384
340,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.350409782938233,0.84716718110361
341,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Down,0.353178565333141,0.85022552048249
342,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.355248154677354,0.85022552048249
343,WP_NOTCH_SIGNALING_WP61,48,Down,0.356900963860397,0.85022552048249
344,WP_GPCRS_OTHER,11,Down,0.357174844370937,0.85022552048249
345,WP_TCELL_ACTIVATION_SARSCOV2,60,Down,0.357961069115914,0.85022552048249
346,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Down,0.357975914142738,0.85022552048249
347,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.358975867831555,0.85022552048249
348,WP_UROTENSINIIMEDIATED_SIGNALING,48,Down,0.360346835587507,0.85022552048249
349,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Down,0.361479469244215,0.85022552048249
350,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Down,0.364103253147018,0.85022552048249
351,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Down,0.36658232575361,0.85022552048249
352,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,60,Up,0.366595949753885,0.85022552048249
353,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,35,Up,0.367423934292157,0.85022552048249
354,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.368691497412997,0.85022552048249
355,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.368959918351587,0.85022552048249
356,WP_FOCAL_ADHESION,113,Down,0.369107603459386,0.85022552048249
357,WP_PROTEASOME_DEGRADATION,57,Down,0.369258528968673,0.85022552048249
358,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Down,0.370872749706405,0.851556983962752
359,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.373411004984659,0.854996785786601
360,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,11,Down,0.375084051882981,0.85644191846614
361,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Up,0.376361299099824,0.856977805706525
362,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.3782270445988,0.858645851740988
363,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.380691693952509,0.858645851740988
364,WP_COPPER_HOMEOSTASIS,39,Up,0.381737173924243,0.858645851740988
365,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.382498729972524,0.858645851740988
366,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.382789899545266,0.858645851740988
367,WP_RETINOBLASTOMA_GENE_IN_CANCER,66,Up,0.383361347431804,0.858645851740988
368,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.386195297712789,0.862242353110977
369,WP_CYTOSINE_METHYLATION,7,Up,0.38706499792938,0.862242353110977
370,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Down,0.388785973092941,0.863735324006479
371,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,11,Down,0.391077031027473,0.866483340982703
372,WP_TP53_NETWORK,16,Down,0.395464858211464,0.86834380789151
373,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.395983258635065,0.86834380789151
374,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.39696439362039,0.86834380789151
375,WP_WNT_SIGNALING_WP363,36,Up,0.398210852336897,0.86834380789151
376,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Down,0.399199022837846,0.86834380789151
377,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.400640707010171,0.86834380789151
378,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,82,Down,0.401037758000506,0.86834380789151
379,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.402430369058584,0.86834380789151
380,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.403595389624458,0.86834380789151
381,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,41,Up,0.403677697404685,0.86834380789151
382,WP_GLUCOCORTICOID_BIOSYNTHESIS,5,Up,0.403914849619098,0.86834380789151
383,WP_PARKINSONS_DISEASE_PATHWAY,26,Up,0.405458903623713,0.86834380789151
384,WP_ENDOTHELIN_PATHWAYS,12,Up,0.405649662080706,0.86834380789151
385,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.409273819894015,0.872523167756379
386,WP_ADIPOGENESIS,84,Up,0.409724991184869,0.872523167756379
387,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.411442348460799,0.873916306033016
388,WP_ALZHEIMERS_DISEASE,182,Down,0.414045389568677,0.874923676672114
389,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,182,Down,0.414045389568677,0.874923676672114
390,WP_INFLAMMATORY_RESPONSE_PATHWAY,12,Down,0.41620398215731,0.877229931623868
391,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,35,Down,0.4186574103027,0.880144223193912
392,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.420916894605752,0.880942567134352
393,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,14,Down,0.421180570418249,0.880942567134352
394,WP_AGERAGE_PATHWAY,54,Down,0.429205380832397,0.887881500351906
395,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.429922173704746,0.887881500351906
396,WP_KALLMANN_SYNDROME,11,Down,0.430882871121198,0.887881500351906
397,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.430999896334793,0.887881500351906
398,WP_ASPIRIN_AND_MIRNAS,8,Down,0.431340372440025,0.887881500351906
399,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.432149330947463,0.887881500351906
400,WP_INTERFERONMEDIATED_SIGNALING,15,Down,0.43235579554861,0.887881500351906
401,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Up,0.435088217215467,0.887881500351906
402,WP_PLEURAL_MESOTHELIOMA,244,Down,0.436191198846355,0.887881500351906
403,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,124,Up,0.436813913567719,0.887881500351906
404,WP_AUTOPHAGY,27,Down,0.437884602478142,0.887881500351906
405,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,45,Up,0.438016958102057,0.887881500351906
406,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.440637298247391,0.887881500351906
407,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Down,0.443215465172972,0.887881500351906
408,WP_CANNABINOID_RECEPTOR_SIGNALING,16,Up,0.444343364659252,0.887881500351906
409,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.445757274342137,0.887881500351906
410,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.446116676675889,0.887881500351906
411,WP_SYNAPTIC_VESICLE_PATHWAY,19,Up,0.447987326280476,0.887881500351906
412,WP_CORI_CYCLE,11,Up,0.448102386118116,0.887881500351906
413,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Up,0.449221428574513,0.887881500351906
414,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.44953711332438,0.887881500351906
415,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,46,Up,0.45032357546732,0.887881500351906
416,WP_OSTEOCLAST_SIGNALING,7,Down,0.45042433349499,0.887881500351906
417,WP_15Q25_COPY_NUMBER_VARIATION,28,Down,0.451762896976395,0.887881500351906
418,WP_FOXA2_PATHWAY,9,Down,0.452705392492978,0.887881500351906
419,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,25,Up,0.456379289446615,0.887881500351906
420,WP_MATRIX_METALLOPROTEINASES,8,Up,0.456534962719885,0.887881500351906
421,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.457175131523939,0.887881500351906
422,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Down,0.458525486324624,0.887881500351906
423,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.458887807624606,0.887881500351906
424,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,59,Down,0.459045026518211,0.887881500351906
425,WP_NAD_METABOLISM,11,Down,0.460282227658024,0.887881500351906
426,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.460410774831672,0.887881500351906
427,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.461429081324198,0.887881500351906
428,WP_SPINAL_CORD_INJURY,63,Down,0.462303262956954,0.887881500351906
429,WP_SLEEP_REGULATION,10,Down,0.464366892365902,0.889765933624176
430,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,14,Down,0.46647080617693,0.891718610877759
431,WP_NRXN1_DELETION_SYNDROME,2,Down,0.472691020748027,0.897900854114636
432,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,45,Up,0.472977782277225,0.897900854114636
433,WP_MINERALOCORTICOID_BIOSYNTHESIS,4,Up,0.472981836778148,0.897900854114636
434,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.475817473825839,0.898352657291078
435,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,45,Down,0.476084583704917,0.898352657291078
436,WP_HEDGEHOG_SIGNALING_WP4249,24,Down,0.476498489755365,0.898352657291078
437,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.47871712266721,0.900470194124591
438,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.482580930766801,0.903851072868699
439,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.482884289294854,0.903851072868699
440,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.487981528480342,0.903851072868699
441,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.488199307477629,0.903851072868699
442,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.489075283170742,0.903851072868699
443,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.489181796759893,0.903851072868699
444,WP_NEOVASCULARIZATION_PROCESSES,20,Down,0.489244923160963,0.903851072868699
445,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.491710090958673,0.903851072868699
446,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Up,0.492017477761342,0.903851072868699
447,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.492328178355033,0.903851072868699
448,WP_NAD_BIOSYNTHETIC_PATHWAYS,19,Down,0.493767266814233,0.903851072868699
449,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,28,Up,0.495614383216513,0.903851072868699
450,WP_HEART_DEVELOPMENT,16,Up,0.495716994819865,0.903851072868699
451,WP_ONECARBON_METABOLISM,22,Up,0.496565554710182,0.903851072868699
452,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,70,Up,0.497970748184586,0.903851072868699
453,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Down,0.49810770804078,0.903851072868699
454,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.501150109104237,0.903905210600196
455,WP_CILIARY_LANDSCAPE,183,Up,0.50196270443296,0.903905210600196
456,WP_GPCRS_CLASS_A_RHODOPSINLIKE,40,Down,0.502130637373355,0.903905210600196
457,WP_TYPE_II_INTERFERON_SIGNALING,29,Up,0.502536108569695,0.903905210600196
458,WP_PPARALPHA_PATHWAY,15,Up,0.504486790387974,0.905432623796757
459,WP_ARYLAMINE_METABOLISM,1,Up,0.505916214178474,0.905700115421339
460,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Down,0.508414065657501,0.905700115421339
461,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.508894478503747,0.905700115421339
462,WP_PROTEOGLYCAN_BIOSYNTHESIS,14,Down,0.510113209218495,0.905700115421339
463,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,7,Down,0.510144955523212,0.905700115421339
464,WP_NONSMALL_CELL_LUNG_CANCER,57,Down,0.511672975633476,0.90645514217827
465,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Down,0.513340667443273,0.907453825028754
466,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,27,Up,0.514669438389635,0.907574229144962
467,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Up,0.518337158130873,0.907574229144962
468,WP_HEPATITIS_B_INFECTION,116,Down,0.51865092023332,0.907574229144962
469,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.519063632555071,0.907574229144962
470,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Up,0.52043088167935,0.907574229144962
471,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,36,Up,0.520452296320447,0.907574229144962
472,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,8,Down,0.52113751357229,0.907574229144962
473,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.522719441612904,0.908404611005935
474,WP_IL7_SIGNALING,23,Down,0.525369805142049,0.910671803695719
475,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.526239789240227,0.910671803695719
476,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,89,Up,0.535689827387136,0.916327311726317
477,WP_P38_MAPK_SIGNALING,31,Up,0.537345022850232,0.916327311726317
478,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Down,0.538341468360331,0.916327311726317
479,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,77,Down,0.538364228823097,0.916327311726317
480,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.543883644172867,0.916327311726317
481,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,31,Up,0.546539095601668,0.916327311726317
482,WP_FOXP3_IN_COVID19,9,Down,0.546999173343368,0.916327311726317
483,WP_RAC1PAK1P38MMP2_PATHWAY,51,Down,0.547762796714601,0.916327311726317
484,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.548824865254446,0.916327311726317
485,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Up,0.549291184989333,0.916327311726317
486,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.550754559706982,0.916327311726317
487,WP_ATM_SIGNALING,34,Up,0.553535560768638,0.916327311726317
488,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.554562449314421,0.916327311726317
489,WP_HEME_BIOSYNTHESIS,8,Up,0.554562449314421,0.916327311726317
490,WP_ENERGY_METABOLISM,41,Down,0.55590710266799,0.916327311726317
491,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,5,Down,0.556564081494093,0.916327311726317
492,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.557231707239578,0.916327311726317
493,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.558220211470014,0.916327311726317
494,WP_PURINERGIC_SIGNALING,14,Down,0.558579838907882,0.916327311726317
495,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Down,0.562172965001486,0.916327311726317
496,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.562256611056594,0.916327311726317
497,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.566446293287838,0.916327311726317
498,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.566957933413537,0.916327311726317
499,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.567972192119702,0.916327311726317
500,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,70,Down,0.568259289911804,0.916327311726317
501,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.569214754467254,0.916327311726317
502,WP_PDGF_PATHWAY,35,Down,0.570172054344081,0.916327311726317
503,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Up,0.570543359421389,0.916327311726317
504,WP_FATTY_ACID_BETAOXIDATION,28,Down,0.57082769541376,0.916327311726317
505,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,130,Down,0.571336063987062,0.916327311726317
506,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.571567967173327,0.916327311726317
507,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,43,Down,0.572039772415167,0.916327311726317
508,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Up,0.572247986015965,0.916327311726317
509,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Down,0.572703808024307,0.916327311726317
510,WP_NOTCH_SIGNALING_WP268,34,Up,0.575970557867206,0.916327311726317
511,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Up,0.57625837147533,0.916327311726317
512,WP_INTEGRATED_CANCER_PATHWAY,38,Down,0.576329460671638,0.916327311726317
513,WP_ID_SIGNALING,12,Down,0.576718586894786,0.916327311726317
514,WP_RETT_SYNDROME,31,Down,0.579040402460782,0.916327311726317
515,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,52,Down,0.579632331622274,0.916327311726317
516,WP_DRAVET_SYNDROME,12,Down,0.58045904213069,0.916327311726317
517,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Down,0.580796844099849,0.916327311726317
518,WP_MEASLES_VIRUS_INFECTION,98,Up,0.58345664896904,0.916327311726317
519,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Down,0.584421855116301,0.916327311726317
520,WP_AXON_GUIDANCE,35,Up,0.585928724711095,0.916327311726317
521,WP_KLEEFSTRA_SYNDROME,24,Down,0.585944958096692,0.916327311726317
522,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,76,Up,0.586262275395784,0.916327311726317
523,WP_IL19_SIGNALING,20,Up,0.586710755596832,0.916327311726317
524,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,16,Down,0.586731145239597,0.916327311726317
525,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.587858559397108,0.916327311726317
526,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Up,0.587875874853434,0.916327311726317
527,WP_PYRIMIDINE_METABOLISM,71,Down,0.588537499697117,0.916327311726317
528,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.588589806072379,0.916327311726317
529,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Down,0.593320812468722,0.918003667714193
530,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.593563616275633,0.918003667714193
531,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,46,Up,0.594162339982617,0.918003667714193
532,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.594827806813702,0.918003667714193
533,WP_MESODERMAL_COMMITMENT_PATHWAY,75,Down,0.598167830553417,0.918003667714193
534,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,45,Down,0.598893682826277,0.918003667714193
535,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.599772881134541,0.918003667714193
536,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.601370238159042,0.918003667714193
537,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,42,Up,0.602765796990795,0.918003667714193
538,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.603850768882959,0.918003667714193
539,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.604370706932391,0.918003667714193
540,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.604802269215079,0.918003667714193
541,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.605999354028239,0.918003667714193
542,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.608178183120917,0.918003667714193
543,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.60997347805461,0.918003667714193
544,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.610540635763646,0.918003667714193
545,WP_PDGFRBETA_PATHWAY,27,Down,0.610812225417189,0.918003667714193
546,WP_MAPK_SIGNALING,156,Down,0.612179056303616,0.918003667714193
547,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.61316178930943,0.918003667714193
548,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.614488658472842,0.918003667714193
549,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,88,Up,0.615157361580212,0.918003667714193
550,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Down,0.616243818243403,0.918003667714193
551,WP_TNFALPHA_SIGNALING,82,Down,0.618388396092345,0.918003667714193
552,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.618820174483544,0.918003667714193
553,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,16,Up,0.619233909931523,0.918003667714193
554,WP_OVARIAN_INFERTILITY,20,Up,0.621888924756348,0.918003667714193
555,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Down,0.622408633625653,0.918003667714193
556,WP_NEURAL_CREST_DIFFERENTIATION,37,Up,0.624684113342097,0.918003667714193
557,WP_KETOGENESIS_AND_KETOLYSIS,5,Up,0.62541901257103,0.918003667714193
558,WP_PROSTAGLANDIN_SIGNALING,20,Down,0.625619509387131,0.918003667714193
559,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.625715798775198,0.918003667714193
560,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.62576297559284,0.918003667714193
561,WP_IL9_SIGNALING,15,Down,0.628523508217794,0.918003667714193
562,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.62936450585567,0.918003667714193
563,WP_IRON_METABOLISM_DISORDERS,10,Up,0.629494659190749,0.918003667714193
564,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Down,0.629871129672512,0.918003667714193
565,WP_OPIOID_RECEPTOR_PATHWAYS,24,Down,0.632374017945611,0.920020252657155
566,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Down,0.63463344544302,0.92167613454799
567,WP_HISTONE_MODIFICATIONS,36,Up,0.636536626676587,0.922809712748067
568,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Up,0.639173121108448,0.925000537942155
569,WP_METASTATIC_BRAIN_TUMOR,5,Up,0.641746460443585,0.927092426159275
570,WP_13Q1212_COPY_NUMBER_VARIATION,20,Up,0.644082216757709,0.927375673593139
571,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.64505298862264,0.927375673593139
572,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.646818105066141,0.927375673593139
573,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Down,0.647553344355589,0.927375673593139
574,WP_VITAMIN_B12_DISORDERS,9,Up,0.647587697336739,0.927375673593139
575,WP_HIPPOYAP_SIGNALING,16,Up,0.650260871777056,0.927375673593139
576,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.650447141824149,0.927375673593139
577,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Down,0.650968082315379,0.927375673593139
578,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.656309475521633,0.932133926762662
579,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,10,Down,0.656576087099247,0.932133926762662
580,WP_RETINOL_METABOLISM,6,Down,0.658423012179886,0.933144337951494
581,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.659779916198826,0.93345798815049
582,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.661330371726468,0.934043927077589
583,WP_IL2_SIGNALING,37,Down,0.668398604452596,0.942407637838824
584,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.669950058463687,0.942977650782793
585,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.67162647913296,0.943721309140672
586,WP_G13_SIGNALING,29,Down,0.674273739358347,0.945824255550445
587,WP_NUCLEOTIDE_GPCRS,5,Down,0.675753793876138,0.946036637750114
588,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.677347303974233,0.946036637750114
589,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.678226654514179,0.946036637750114
590,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.679028730258597,0.946036637750114
591,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,40,Up,0.680913339937124,0.946121679433071
592,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,2,Down,0.682396440177961,0.946121679433071
593,WP_CCL18_SIGNALING,20,Down,0.682542768739429,0.946121679433071
594,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.686399870169018,0.949866487001571
595,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.692394614059531,0.953879311150994
596,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.694158265593962,0.953879311150994
597,WP_ALSTROM_SYNDROME,27,Up,0.694357190491846,0.953879311150994
598,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.695575358230742,0.953879311150994
599,WP_IL4_SIGNALING,50,Down,0.696277507079343,0.953879311150994
600,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Up,0.699276328531801,0.953879311150994
601,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.70286542840686,0.953879311150994
602,WP_NEPHROGENESIS,4,Up,0.703508534641336,0.953879311150994
603,WP_GASTRIC_CANCER_NETWORK_1,15,Up,0.703604822450674,0.953879311150994
604,WP_WNT_SIGNALING_AND_PLURIPOTENCY,58,Up,0.703827869668253,0.953879311150994
605,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.704833893905709,0.953879311150994
606,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,47,Down,0.707116420684393,0.953879311150994
607,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,56,Down,0.707329036003853,0.953879311150994
608,WP_CILIOPATHIES,123,Up,0.70756572664606,0.953879311150994
609,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.707813954340872,0.953879311150994
610,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,6,Down,0.70786664209502,0.953879311150994
611,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.713808188748459,0.955392804241833
612,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.715069698688655,0.955392804241833
613,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,9,Up,0.716027032500694,0.955392804241833
614,WP_TGFB_SMAD_SIGNALING,7,Up,0.717462088630881,0.955392804241833
615,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.719579910226058,0.955392804241833
616,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,29,Down,0.720216338691242,0.955392804241833
617,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.720642631488748,0.955392804241833
618,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.722565041945585,0.955392804241833
619,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.726730966691232,0.955392804241833
620,WP_ENDODERM_DIFFERENTIATION,79,Up,0.726868809229249,0.955392804241833
621,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.728040041419827,0.955392804241833
622,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.728592527502253,0.955392804241833
623,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.729647572901753,0.955392804241833
624,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Down,0.730249276648232,0.955392804241833
625,WP_BLADDER_CANCER,28,Down,0.731154627427726,0.955392804241833
626,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.732119642407236,0.955392804241833
627,WP_G_PROTEIN_SIGNALING,61,Down,0.732783216949228,0.955392804241833
628,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.733018625618946,0.955392804241833
629,WP_COMPLEMENT_SYSTEM,46,Up,0.733540543890417,0.955392804241833
630,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.734091274234738,0.955392804241833
631,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.734127172820042,0.955392804241833
632,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.73643478026593,0.955392804241833
633,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Up,0.737424701170003,0.955392804241833
634,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Down,0.739631372815133,0.955392804241833
635,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.742207017985762,0.955392804241833
636,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.742304433141631,0.955392804241833
637,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,16,Down,0.742319698014969,0.955392804241833
638,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.744131306283244,0.955392804241833
639,WP_BDNFTRKB_SIGNALING,26,Up,0.744375298563315,0.955392804241833
640,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.745056133293566,0.955392804241833
641,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.746161405481831,0.955392804241833
642,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,3,Down,0.749181256349289,0.955392804241833
643,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.752058966823668,0.955392804241833
644,WP_BARDETBIEDL_SYNDROME,65,Up,0.752584076004418,0.955392804241833
645,WP_BASE_EXCISION_REPAIR,29,Up,0.752826569425739,0.955392804241833
646,WP_VEGFAVEGFR2_SIGNALING,333,Down,0.75380204735171,0.955392804241833
647,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.754758714826286,0.955392804241833
648,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.756291383502688,0.955392804241833
649,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,12,Up,0.756352102533397,0.955392804241833
650,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Up,0.757209755397059,0.955392804241833
651,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.757478290002467,0.955392804241833
652,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.758882627193602,0.955392804241833
653,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.758967762980434,0.955392804241833
654,WP_MIRNA_BIOGENESIS,6,Up,0.762408857093084,0.955885227436906
655,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,15,Up,0.762641110232188,0.955885227436906
656,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.762847578100499,0.955885227436906
657,WP_DNA_MISMATCH_REPAIR,21,Up,0.765976342066836,0.955935252430757
658,WP_IDO_METABOLIC_PATHWAY,7,Up,0.766038656337297,0.955935252430757
659,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Up,0.767139650239973,0.955935252430757
660,WP_ANGIOGENESIS,12,Down,0.76753925377652,0.955935252430757
661,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Up,0.77436468304569,0.961929430542177
662,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.77506589016056,0.961929430542177
663,WP_ACUTE_VIRAL_MYOCARDITIS,63,Down,0.776542194043431,0.961929430542177
664,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.778285478990889,0.961929430542177
665,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.77955781121535,0.961929430542177
666,WP_PI3KAKT_SIGNALING,172,Down,0.78284119804272,0.961929430542177
667,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Down,0.785311473327897,0.961929430542177
668,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.786633939005815,0.961929430542177
669,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.787039952247976,0.961929430542177
670,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Down,0.787979122870941,0.961929430542177
671,WP_PRIMARY_OVARIAN_INSUFFICIENCY,86,Up,0.788317859906762,0.961929430542177
672,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.788337281520727,0.961929430542177
673,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Down,0.789377551561699,0.961929430542177
674,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.791091880754706,0.961929430542177
675,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.79131682174913,0.961929430542177
676,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,10,Up,0.791918132231477,0.961929430542177
677,WP_DISORDERS_IN_KETOLYSIS,3,Down,0.792246015178897,0.961929430542177
678,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,50,Down,0.795913278890775,0.962947818045695
679,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.798173635998042,0.962947818045695
680,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.798173635998042,0.962947818045695
681,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,27,Down,0.798239244290471,0.962947818045695
682,WP_COMPLEMENT_ACTIVATION,11,Down,0.799243529098786,0.962947818045695
683,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.802228154983858,0.962947818045695
684,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.803173137127204,0.962947818045695
685,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.804656421445931,0.962947818045695
686,WP_GLUTATHIONE_METABOLISM,10,Up,0.805184816054577,0.962947818045695
687,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,20,Down,0.805516771985075,0.962947818045695
688,WP_ECTODERM_DIFFERENTIATION,74,Up,0.806284139413588,0.962947818045695
689,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.808292360086598,0.962947818045695
690,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.808313861863175,0.962947818045695
691,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,12,Down,0.814166669632767,0.968516646075448
692,WP_GABA_RECEPTOR_SIGNALING,9,Up,0.816333204704276,0.969690598651611
693,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,17,Down,0.819507597621588,0.97177029054814
694,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Up,0.820675103148944,0.97177029054814
695,WP_DNA_REPLICATION,35,Up,0.821630598456152,0.97177029054814
696,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.82452896449846,0.972394751495639
697,WP_FERROPTOSIS,50,Down,0.827452839741185,0.972394751495639
698,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.827579922689458,0.972394751495639
699,WP_SPINA_BIFIDA,10,Down,0.828535544366513,0.972394751495639
700,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.829472490650092,0.972394751495639
701,WP_WNT_SIGNALING_WP428,57,Up,0.831112670310214,0.972394751495639
702,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.831128454744951,0.972394751495639
703,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.831622275305881,0.972394751495639
704,WP_CIRCADIAN_RHYTHM_GENES,114,Down,0.833538561379506,0.973250990701639
705,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Down,0.836918909185296,0.973994965976675
706,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.838429531075118,0.973994965976675
707,WP_EICOSANOID_SYNTHESIS,13,Up,0.839899172106895,0.973994965976675
708,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,29,Down,0.840034046953907,0.973994965976675
709,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.841491911840166,0.973994965976675
710,WP_TARGET_OF_RAPAMYCIN_SIGNALING,31,Down,0.842739649872714,0.973994965976675
711,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.847251589583467,0.973994965976675
712,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.848937135183166,0.973994965976675
713,WP_EGFEGFR_SIGNALING,136,Up,0.849072584472205,0.973994965976675
714,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Up,0.849714440175506,0.973994965976675
715,WP_PRION_DISEASE_PATHWAY,28,Down,0.85134800489662,0.973994965976675
716,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,13,Up,0.85239016597022,0.973994965976675
717,WP_CELLULAR_PROTEOSTASIS,6,Down,0.852440952158701,0.973994965976675
718,WP_BREAST_CANCER_PATHWAY,83,Down,0.853023077499411,0.973994965976675
719,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,55,Down,0.853494415968681,0.973994965976675
720,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.853738726001982,0.973994965976675
721,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.854319185485623,0.973994965976675
722,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.859582019254089,0.977819510153633
723,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Up,0.86084019065921,0.977819510153633
724,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.863718411758976,0.977819510153633
725,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,31,Down,0.864134953713935,0.977819510153633
726,WP_VALPROIC_ACID_PATHWAY,8,Down,0.864209131190425,0.977819510153633
727,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.86542031718742,0.977819510153633
728,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.869625301449126,0.977819510153633
729,WP_PREIMPLANTATION_EMBRYO,20,Down,0.870766664787521,0.977819510153633
730,WP_TRANSSULFURATION_PATHWAY,8,Up,0.870872501667855,0.977819510153633
731,WP_HIPPO_SIGNALING_REGULATION,43,Down,0.870917247171649,0.977819510153633
732,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.872977323923579,0.977819510153633
733,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.873422018060745,0.977819510153633
734,WP_VITAMIN_D_METABOLISM,6,Up,0.873886493569182,0.977819510153633
735,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.87648419392005,0.977819510153633
736,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.876640064609795,0.977819510153633
737,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,82,Down,0.87696505116705,0.977819510153633
738,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.879996081437273,0.977819510153633
739,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.88202753644546,0.977819510153633
740,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.88227948675113,0.977819510153633
741,WP_PEPTIDE_GPCRS,13,Up,0.882490110437519,0.977819510153633
742,WP_DOPAMINERGIC_NEUROGENESIS,4,Down,0.882654594323596,0.977819510153633
743,WP_IL3_SIGNALING,46,Down,0.885050160027182,0.978087003492384
744,WP_IL6_SIGNALING,38,Up,0.885275827978508,0.978087003492384
745,WP_SPHINGOLIPID_PATHWAY,20,Up,0.886840874957567,0.978500938543785
746,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.888448006892264,0.978960136280752
747,WP_GLYCOLYSIS_IN_SENESCENCE,11,Up,0.8902003510996,0.979577896390725
748,WP_NUCLEAR_RECEPTORS,20,Down,0.893429132814931,0.98029199165606
749,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,19,Down,0.897768146458896,0.98029199165606
750,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Up,0.897967201126852,0.98029199165606
751,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Down,0.898146785619961,0.98029199165606
752,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.898407824408562,0.98029199165606
753,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.899215578525017,0.98029199165606
754,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Up,0.902098285300073,0.98029199165606
755,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,11,Down,0.902118032915894,0.98029199165606
756,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,6,Down,0.903334080104303,0.98029199165606
757,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.903668662307207,0.98029199165606
758,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Down,0.904423691062056,0.98029199165606
759,WP_CHOLESTASIS,9,Up,0.905390261682664,0.98029199165606
760,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.907733221147772,0.98029199165606
761,WP_5Q35_COPY_NUMBER_VARIATION,75,Up,0.908044755022632,0.98029199165606
762,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.90893081133249,0.98029199165606
763,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,28,Down,0.911505755394452,0.98029199165606
764,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.911971108500989,0.98029199165606
765,WP_CANCER_PATHWAYS,293,Up,0.91231553967991,0.98029199165606
766,WP_STEROID_BIOSYNTHESIS,2,Down,0.913946192840446,0.9807621024998
767,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,0.915899070739999,0.981044283580784
768,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.917577325804502,0.981044283580784
769,WP_GALANIN_RECEPTOR_PATHWAY,10,Down,0.917789603495892,0.981044283580784
770,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.918985231994484,0.981046572336969
771,WP_BURN_WOUND_HEALING,59,Down,0.924768744887339,0.984147583118169
772,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,49,Down,0.925097029504872,0.984147583118169
773,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.925481851277792,0.984147583118169
774,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.928500761018389,0.985227343994527
775,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.929998076691657,0.985227343994527
776,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.93014196020496,0.985227343994527
777,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.931993023696504,0.985227343994527
778,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Down,0.932490113902362,0.985227343994527
779,WP_TAMOXIFEN_METABOLISM,2,Up,0.935476613056041,0.986175376079965
780,WP_APOPTOSIS,70,Down,0.937039936621278,0.986175376079965
781,WP_RAS_SIGNALING,113,Down,0.938030020485823,0.986175376079965
782,WP_HUNGER_AND_SATIETY,2,Up,0.938186306684347,0.986175376079965
783,WP_FRAGILE_X_SYNDROME,83,Up,0.940462716394311,0.986380549556233
784,WP_IL11_SIGNALING,40,Up,0.940781448725166,0.986380549556233
785,WP_KREBS_CYCLE_DISORDERS,11,Up,0.943897880974869,0.988053806303549
786,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Up,0.944781376830401,0.988053806303549
787,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,19,Up,0.947146315405897,0.988873132239736
788,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.950260833326709,0.988873132239736
789,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,54,Down,0.950693139939341,0.988873132239736
790,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.951090081962624,0.988873132239736
791,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.952426293213342,0.988873132239736
792,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.952782871939016,0.988873132239736
793,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.955001012563201,0.989925387549749
794,WP_MRNA_PROCESSING,124,Down,0.957928724544639,0.990559947766905
795,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.958023307146824,0.990559947766905
796,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.961192434538165,0.991049425200958
797,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,267,Down,0.961933704848486,0.991049425200958
798,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.963802873288185,0.991049425200958
799,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Up,0.964363943419982,0.991049425200958
800,WP_NUCLEAR_RECEPTORS_METAPATHWAY,171,Down,0.966699548380763,0.991049425200958
801,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,0.970055620577781,0.991049425200958
802,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Down,0.972308471045651,0.991049425200958
803,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.972765898855933,0.991049425200958
804,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Down,0.97358103625626,0.991049425200958
805,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.973636229069531,0.991049425200958
806,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.975579903479496,0.991049425200958
807,WP_16P112_DISTAL_DELETION_SYNDROME,20,Down,0.976379421624045,0.991049425200958
808,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Up,0.976964200831976,0.991049425200958
809,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Up,0.977145587043069,0.991049425200958
810,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Up,0.978310201294152,0.991049425200958
811,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,60,Up,0.98052775200197,0.991049425200958
812,WP_NEPHROTIC_SYNDROME,27,Down,0.980577988169222,0.991049425200958
813,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Down,0.981712653922299,0.991049425200958
814,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.982111095478873,0.991049425200958
815,WP_METHYLATION_PATHWAYS,5,Up,0.982609831555694,0.991049425200958
816,WP_AMINO_ACID_METABOLISM,58,Up,0.985652129026421,0.992704797618476
817,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Up,0.986666447267999,0.992704797618476
818,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,35,Down,0.991063204527252,0.994814397863653
819,WP_SEROTONIN_AND_ANXIETY,7,Down,0.992304408113532,0.994814397863653
820,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,38,Up,0.99239392487615,0.994814397863653
821,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.996209684963892,0.9974230950552
822,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.999825598806844,0.999825598806844
